Locally advanced pancreatic cancer: An emerging entity

Pancreatic adenocarcinoma (PDAC) remains a highly fatal disease that is increasing in incidence. PDAC can be classified according to resectability status with three non-metastatic groups defined: resectable, borderline resectable and locally advanced PDAC (LAPC). Delineating these subtypes is important with the optimal treatment approach dictated by high quality CT imaging and multidisciplinary team discussion. Patients with LAPC are thought unresectable and are therefore rarely cured. In these patients chemotherapy remains the mainstay of treatment.
Source: Current Problems in Cancer - Category: Cancer & Oncology Authors: Source Type: research